Metavisio (Thomson Computing) Total Liabilities

Latest as of December 2025: €45.52 Million EUR ≈ $53.22 Million USD

Metavisio (Thomson Computing) total liabilities. Based on the latest financial reports, Metavisio (Thomson Computing) (ALTHO) has total liabilities worth €45.52 Million EUR (≈ $53.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Metavisio (Thomson Computing) (ALTHO) defensive interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Metavisio (Thomson Computing) (2017–2025)

Total liabilities of Metavisio (Thomson Computing) from 2017 to 2025. This chart illustrates how Metavisio (Thomson Computing)'s total liabilities have evolved over time, based on quarterly financial data.

Metavisio (Thomson Computing) Competitors by Total Liabilities

The table below lists competitors of Metavisio (Thomson Computing) ranked by their total liabilities.

Company Country Total Liabilities
MultiMetaVerse Holdings Limited
NASDAQ:MMV
USA $35.87 Million
Aethlon Medical Inc
NASDAQ:AEMD
USA $1.04 Million
Stelmine Canada Ltd
V:STH
Canada CA$616.27K
Rover Metals Corp
V:ROVR
Canada CA$992.88K
Alligator Bioscience AB
ST:ATORX
Sweden Skr61.79 Million
Optiva Inc
TO:OPT
Canada CA$134.78 Million
Arctic Blue Beverages AB
ST:ARCTIC
Sweden Skr22.39 Million
Lithium One Metals Inc
V:LONE
Canada CA$3.13 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Metavisio (Thomson Computing)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Metavisio (Thomson Computing).

Liquidity & Leverage Metrics

Metavisio (Thomson Computing) Total Liabilities Ratios Explained

Metavisio (Thomson Computing) total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 2.66 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Metavisio (Thomson Computing)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Metavisio (Thomson Computing) (2017–2025)

The table below shows the annual total liabilities of Metavisio (Thomson Computing) from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 €45.52 Million
≈ $53.22 Million
-16.86%
2024-12-31 €54.75 Million
≈ $64.01 Million
+16.20%
2023-12-31 €47.12 Million
≈ $55.09 Million
+35.44%
2022-12-31 €34.79 Million
≈ $40.67 Million
-13.30%
2021-12-31 €40.13 Million
≈ $46.91 Million
-34.97%
2020-12-31 €61.71 Million
≈ $72.14 Million
+6889.47%
2019-12-31 €882.87K
≈ $1.03 Million
-96.93%
2018-12-31 €28.77 Million
≈ $33.63 Million
+81.53%
2017-12-31 €15.85 Million
≈ $18.53 Million
--

About Metavisio (Thomson Computing)

PA:ALTHO France Computer Hardware
Market Cap
$1.11 Million
€945.93K EUR
Market Cap Rank
#30603 Global
#570 in France
Share Price
€0.00
Change (1 day)
-11.11%
52-Week Range
€0.00 - €0.01
All Time High
€14.10
About

Metavisio designs, markets, and sells IT products in France and internationally. It offers laptops and tablets. The company was founded in 2013 and is based in Dammarie-les-Lys, France.